Use of Thermal Ablation in Low-Resource Settings: Experience From Three Multicenter Noninferiority Randomized Clinical Trials
JCO Global Oncology · 2025-06 · (11)
DOI: 10.1200/go-25-00050 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JCO Global Oncology, 2025-06. Verfasst von Gabriel Conzuelo Rodriguez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Basic Health International, Pittsburgh, PA. Hauptthemen laut MEDLINE: Ablation Techniques, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization, NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Thermal ablation (TA) is now a widely used treatment for cervical precancer in low- and middle-income countries. Over the past decade, TA devices have been redesigned to be more portable, user-friendly, and affordable. This analysis combines data from three large randomized clinical trials comparing the efficacy, safety, and acceptability of TA with those of the previous standard, gas-based cryotherapy. METHODS This analysis used Human Papillomavirus (HPV) test results at 1-year post-treatment as the primary outcome. Secondary outcomes included side effects and patient satisfaction. RESULTS Of the 2,948 participants treated with either TA or gas-based cryotherapy, 80.9% and 81.8% completed HPV testing at 1 year, respectively. Overall, 60.7% tested negative for HPV at follow-up, with slightly higher rates in the TA group (62.5%) compared with cryotherapy (58.7%), although the difference was not statistically significant ( P value = .14). Side effects were minimal for both treatments. Severe pain was slightly more common with TA (7.6% v 3.9% for cryotherapy), but vasovagal responses were less frequent (2.3% v 7.6%). Satisfaction with treatment was high (approximately 98%) across both groups. CONCLUSION Our findings support the efficacy of TA in treating cervical precancer, offering an effective and practical alternative in low-resource settings. However, future research is urgently needed to address critical questions, including the standardization of treatment protocols and tailored approaches for women living with HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Basic Health International, Pittsburgh, PA.
- Cleveland Clinic Lerner College of Medicine, Cleveland, OH.
- International Agency for Research on Cancer, Lyon, France.
ORCID-Profile: Miriam L Cremer, Richard Muwonge, Partha Basu
Förderung
- World Health Organization
- NCI NIH HHS
Zitieren
APA
Conzuelo Rodriguez, G., Cremer, M. L., Muwonge, R., & Basu, P. (2025). Use of Thermal Ablation in Low-Resource Settings: Experience From Three Multicenter Noninferiority Randomized Clinical Trials. JCO Global Oncology. https://doi.org/10.1200/go-25-00050
Vancouver
Conzuelo Rodriguez G, Cremer ML, Muwonge R, Basu P. Use of Thermal Ablation in Low-Resource Settings: Experience From Three Multicenter Noninferiority Randomized Clinical Trials. JCO Global Oncology. 2025. doi:10.1200/go-25-00050
BibTeX
@article{ConzueloRodriguez2025,
author = {Conzuelo Rodriguez, Gabriel and Cremer, Miriam L and Muwonge, Richard and Basu, Partha},
title = {Use of Thermal Ablation in Low-Resource Settings: Experience From Three Multicenter Noninferiority Randomized Clinical Trials},
journal = {JCO Global Oncology},
year = {2025},
number = {11},
doi = {10.1200/go-25-00050}
}
EUVIMED